Back
Zoetis 10K Form
Buy
54
ZTS
Zoetis
Last Price:
192.41
Seasonality Move:
5.08%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-08-06 | 10Q | ZTS/Zoetis Quarterly |
| 2020-05-06 | 10Q | ZTS/Zoetis Quarterly |
| 2020-02-13 | 10K | ZTS/Zoetis Annual |
| 2019-11-07 | 10Q | ZTS/Zoetis Quarterly |
| 2019-08-09 | 10Q | ZTS/Zoetis Quarterly |
| 2019-08-06 | 10Q | ZTS/Zoetis Quarterly |
Receive ZTS News And Ratings
See the #1 stock for the next 7 days that we like better than ZTS
ZTS Financial Statistics
Sales & Book Value
| Annual Sales: | $8.08B |
|---|---|
| Cash Flow: | $17M |
| Price / Cash Flow: | 69.79 |
| Annual Sales: | $10.04 |
| Price / Book: | 19.16 |
Profitability
| EPS (TTM): | 4.76000 |
|---|---|
| Net Income (TTM): | $2.21B |
| Gross Margin: | $5.63B |
| Return on Equity: | 48.6% |
| Return on Assets: | 15.84% |
Zoetis Earnings Forecast
Key Zoetis Financial Ratios
- The Gross Profit Margin over the past 14 years for ZTS is 69.63%.
- The Selling, General & Administrative Expenses for ZTS have been equal to 24.86% of Gross Profit Margin.
- The Research & Development expenses have been 6.67% of Revenue.
- The Interest Expense is 10.45% of Operating Income.
- The Net Earning history of ZTS is 26.16% of Total Revenues.
- Per Share Earnings over the last 14 years have been positive in 12 years.
Zoetis Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Drug Manufacturers - Specialty & Generic |
| Sector: | Healthcare |
| Current Symbol: | ZTS |
| CUSIP: | 98978V |
| Website: | zoetis.com |
Debt
| Debt-to-Equity Ratio: | 1.42 |
|---|---|
| Current Ratio: | 3.5 |
| Quick Ratio: | 1.72 |
Price-to-Earnings
| Trailing P/E Ratio: | 42.88 |
|---|---|
| Forward P/E Ratio: | 31.59 |